Surgery Partners (NASDAQ:SGRY) Shares Up 4.7%

Surgery Partners, Inc. (NASDAQ:SGRYGet Free Report)’s share price shot up 4.7% during mid-day trading on Wednesday . The stock traded as high as $30.04 and last traded at $29.68. 834,745 shares changed hands during mid-day trading, a decline of 14% from the average session volume of 972,236 shares. The stock had previously closed at $28.34.

Analyst Ratings Changes

Several brokerages have recently issued reports on SGRY. Citigroup lowered their target price on shares of Surgery Partners from $42.00 to $38.00 and set a “buy” rating for the company in a report on Wednesday, May 8th. Cantor Fitzgerald reiterated an “overweight” rating and issued a $43.00 price target on shares of Surgery Partners in a research report on Tuesday, July 9th. Benchmark reiterated a “buy” rating and issued a $50.00 price target on shares of Surgery Partners in a research report on Wednesday, May 1st. Finally, Macquarie assumed coverage on shares of Surgery Partners in a research report on Friday, June 28th. They issued an “outperform” rating and a $31.00 price target for the company. Two investment analysts have rated the stock with a hold rating and six have assigned a buy rating to the company’s stock. According to MarketBeat, Surgery Partners presently has a consensus rating of “Moderate Buy” and a consensus target price of $40.14.

Check Out Our Latest Analysis on Surgery Partners

Surgery Partners Stock Performance

The company has a market cap of $3.77 billion, a PE ratio of 32.77, a P/E/G ratio of 2.14 and a beta of 2.78. The company has a debt-to-equity ratio of 0.92, a quick ratio of 1.56 and a current ratio of 1.71. The stock’s 50-day simple moving average is $25.52 and its 200 day simple moving average is $28.08.

Surgery Partners (NASDAQ:SGRYGet Free Report) last announced its quarterly earnings data on Tuesday, May 7th. The company reported $0.06 EPS for the quarter, topping analysts’ consensus estimates of $0.04 by $0.02. The company had revenue of $717.40 million during the quarter, compared to the consensus estimate of $707.66 million. Surgery Partners had a net margin of 0.02% and a return on equity of 3.65%. As a group, equities analysts anticipate that Surgery Partners, Inc. will post 0.88 EPS for the current year.

Insiders Place Their Bets

In other news, insider Danielle Burkhalter sold 6,000 shares of the stock in a transaction dated Wednesday, June 12th. The shares were sold at an average price of $26.39, for a total value of $158,340.00. Following the completion of the transaction, the insider now owns 30,354 shares in the company, valued at approximately $801,042.06. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. 2.30% of the stock is owned by insiders.

Hedge Funds Weigh In On Surgery Partners

A number of large investors have recently made changes to their positions in SGRY. Strs Ohio purchased a new position in shares of Surgery Partners in the 4th quarter valued at about $51,000. DekaBank Deutsche Girozentrale grew its stake in Surgery Partners by 102.0% in the 1st quarter. DekaBank Deutsche Girozentrale now owns 2,723 shares of the company’s stock valued at $80,000 after acquiring an additional 1,375 shares during the last quarter. Mesirow Institutional Investment Management Inc. grew its stake in Surgery Partners by 12.4% in the 4th quarter. Mesirow Institutional Investment Management Inc. now owns 3,388 shares of the company’s stock valued at $108,000 after acquiring an additional 373 shares during the last quarter. Headlands Technologies LLC acquired a new stake in Surgery Partners in the 4th quarter valued at about $145,000. Finally, EntryPoint Capital LLC grew its stake in Surgery Partners by 257.1% in the 1st quarter. EntryPoint Capital LLC now owns 6,399 shares of the company’s stock valued at $191,000 after acquiring an additional 4,607 shares during the last quarter.

Surgery Partners Company Profile

(Get Free Report)

Surgery Partners, Inc, together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery.

Read More

Receive News & Ratings for Surgery Partners Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Surgery Partners and related companies with MarketBeat.com's FREE daily email newsletter.